PATENT CLAIM ANALYSIS

Application Number: 16183216
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "173100"]

Abstract:
The present invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8.

Claim (Index 27):
The method according to  claim 25 , wherein the cancer is uterine corpus cancer.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14021353', '14360694', '15387161', '16012867', '15006560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780242719035288
- 35 USC 102 Novelty (BERT): 0.5370740575781591
- Combined Prediction Score: 0.7559258528895751
- Mean Citation Score: 370.452512
- Max Citation Score: 389.31213
- Similarity Product: 211.61441949394936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test